These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35755947)

  • 41. Generation of macrophages with altered viral sensitivity from genome-edited rhesus macaque iPSCs to model human disease.
    Iwamoto Y; Seki Y; Taya K; Tanaka M; Iriguchi S; Miyake Y; Nakayama EE; Miura T; Shioda T; Akari H; Takaori-Kondo A; Kaneko S
    Mol Ther Methods Clin Dev; 2021 Jun; 21():262-273. PubMed ID: 33869654
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CRISPR/Cas9 Editing of Murine Induced Pluripotent Stem Cells for Engineering Inflammation-Resistant Tissues.
    Brunger JM; Zutshi A; Willard VP; Gersbach CA; Guilak F
    Arthritis Rheumatol; 2017 May; 69(5):1111-1121. PubMed ID: 27813286
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CRISPR-Cas9-Based Genome Editing of Human Induced Pluripotent Stem Cells.
    Giacalone JC; Sharma TP; Burnight ER; Fingert JF; Mullins RF; Stone EM; Tucker BA
    Curr Protoc Stem Cell Biol; 2018 Feb; 44():5B.7.1-5B.7.22. PubMed ID: 29512106
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Generation of an Induced Pluripotent Stem Cell Line with the Constitutive EGFP Reporter.
    Butterfield KT; McGrath PS; Han CM; Kogut I; Bilousova G
    Methods Mol Biol; 2020; 2155():11-21. PubMed ID: 32474864
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An Episomal CRISPR/Cas12a System for Mediating Efficient Gene Editing.
    Duan N; Tang S; Zeng B; Hu Z; Hu Q; Wu L; Zhou M; Liang D
    Life (Basel); 2021 Nov; 11(11):. PubMed ID: 34833137
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Integrate CRISPR/Cas9 for protein expression of HLA-B*38:68Q via precise gene editing.
    Yin Y; Reed EF; Zhang Q
    Sci Rep; 2019 May; 9(1):8067. PubMed ID: 31147565
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HDAC inhibitors improve CRISPR-mediated HDR editing efficiency in iPSCs.
    Zhang JP; Yang ZX; Zhang F; Fu YW; Dai XY; Wen W; Zhang B; Choi H; Chen W; Brown M; Baylink D; Zhang L; Qiu H; Wang C; Cheng T; Zhang XB
    Sci China Life Sci; 2021 Sep; 64(9):1449-1462. PubMed ID: 33420926
    [TBL] [Abstract][Full Text] [Related]  

  • 48. One-step genetic correction of hemoglobin E/beta-thalassemia patient-derived iPSCs by the CRISPR/Cas9 system.
    Wattanapanitch M; Damkham N; Potirat P; Trakarnsanga K; Janan M; U-Pratya Y; Kheolamai P; Klincumhom N; Issaragrisil S
    Stem Cell Res Ther; 2018 Feb; 9(1):46. PubMed ID: 29482624
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Simultaneous reprogramming and gene editing of human fibroblasts.
    Howden SE; Thomson JA; Little MH
    Nat Protoc; 2018 May; 13(5):875-898. PubMed ID: 29622803
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative analysis of mouse and human preimplantation development following POU5F1 CRISPR/Cas9 targeting reveals interspecies differences.
    Stamatiadis P; Boel A; Cosemans G; Popovic M; Bekaert B; Guggilla R; Tang M; De Sutter P; Van Nieuwerburgh F; Menten B; Stoop D; Chuva de Sousa Lopes SM; Coucke P; Heindryckx B
    Hum Reprod; 2021 Apr; 36(5):1242-1252. PubMed ID: 33609360
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Generation of a human induced pluripotent stem cell line JHUi003-A with homozygous mutation for spinocerebellar ataxia type 12 using genome editing.
    Feng H; Li Q; Margolis RL; Li PP
    Stem Cell Res; 2021 May; 53():102346. PubMed ID: 34087983
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Factor-induced Reprogramming and Zinc Finger Nuclease-aided Gene Targeting Cause Different Genome Instability in β-Thalassemia Induced Pluripotent Stem Cells (iPSCs).
    Ma N; Shan Y; Liao B; Kong G; Wang C; Huang K; Zhang H; Cai X; Chen S; Pei D; Chen N; Pan G
    J Biol Chem; 2015 May; 290(19):12079-89. PubMed ID: 25795783
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Naïve Induced Pluripotent Stem Cells Generated From β-Thalassemia Fibroblasts Allow Efficient Gene Correction With CRISPR/Cas9.
    Yang Y; Zhang X; Yi L; Hou Z; Chen J; Kou X; Zhao Y; Wang H; Sun XF; Jiang C; Wang Y; Gao S
    Stem Cells Transl Med; 2016 Jan; 5(1):8-19. PubMed ID: 26676643
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combining Single Strand Oligodeoxynucleotides and CRISPR/Cas9 to Correct Gene Mutations in β-Thalassemia-induced Pluripotent Stem Cells.
    Niu X; He W; Song B; Ou Z; Fan D; Chen Y; Fan Y; Sun X
    J Biol Chem; 2016 Aug; 291(32):16576-85. PubMed ID: 27288406
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficient Production of Biallelic RAG1 Knockout Mouse Embryonic Stem Cell Using CRISPR/Cas9.
    Mehravar M; Shirazi A; Mehrazar MM; Nazari M; Banan M; Salimi M
    Iran J Biotechnol; 2019 Jan; 17(1):e2205. PubMed ID: 31457047
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correction of Hirschsprung-Associated Mutations in Human Induced Pluripotent Stem Cells Via Clustered Regularly Interspaced Short Palindromic Repeats/Cas9, Restores Neural Crest Cell Function.
    Lai FP; Lau ST; Wong JK; Gui H; Wang RX; Zhou T; Lai WH; Tse HF; Tam PK; Garcia-Barcelo MM; Ngan ES
    Gastroenterology; 2017 Jul; 153(1):139-153.e8. PubMed ID: 28342760
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Generation of pluripotent stem cell lines and CRISPR/Cas9 modified isogenic controls from a patient with dilated cardiomyopathy harboring a RBM20 p.R634W mutation.
    Rebs S; Sedaghat-Hamedani F; Kayvanpour E; Meder B; Streckfuss-Bömeke K
    Stem Cell Res; 2020 Jul; 47():101901. PubMed ID: 32674065
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High-throughput assessment of mutations generated by genome editing in induced pluripotent stem cells by high-resolution melting analysis.
    Pham QT; Raad S; Mangahas CL; M'Callum MA; Raggi C; Paganelli M
    Cytotherapy; 2020 Oct; 22(10):536-542. PubMed ID: 32768274
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of genetic quality tests for good manufacturing practice-compliant induced pluripotent stem cells and their derivatives.
    Jo HY; Han HW; Jung I; Ju JH; Park SJ; Moon S; Geum D; Kim H; Park HJ; Kim S; Stacey GN; Koo SK; Park MH; Kim JH
    Sci Rep; 2020 Mar; 10(1):3939. PubMed ID: 32127560
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficient manipulation of gene dosage in human iPSCs using CRISPR/Cas9 nickases.
    Ye T; Duan Y; Tsang HWS; Xu H; Chen Y; Cao H; Chen Y; Fu AKY; Ip NY
    Commun Biol; 2021 Feb; 4(1):195. PubMed ID: 33580208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.